GAB1 and melanoma: Another study has established that MAPK pathway inhibition following BRAF inhibitor treatment induced rapid increases in MET and GAB1 expression [22] and MET amplification was also observed to co-exist with BRAF hotspot mutations and represent the most common amplification among RTKs in melanomas [6].